Board of Trustees of The Leland Stanford Junior University’s Nautilus Biotechnolgy NAUT Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-309,492	Closed	-$1.6M	–	45
2021 Q4	$1.6M	Hold	309,492	–	–	0.1%	20
2021 Q3	$1.9M	Hold	309,492	–	–	0.14%	20
2021 Q2	$3.13M	Buy	+309,492	New	+$3.35M	0.29%	16

Other funds holding NAUT

AEPBI

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

AEPLI

AH Equity Partners LSV II Menlo Park, California $95.6M AUM 8.86% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's NAUT Position: Q1 2022 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Nautilus Biotechnolgy (NAUT) in Q1 2022, closing a stake of 309,492 shares — an estimated $1.6M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in NAUT in Q2 2021 and held it in 3 quarters. The position peaked at $3.13M in Q2 2021. 82 funds tracked by Wall St. Rank hold NAUT as of Q1 2022.

Board of Trustees of The Leland Stanford Junior University reported no remaining Nautilus Biotechnolgy position as of Q1 2022 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 309,492 Nautilus Biotechnolgy shares in Q1 2022, an estimated $1.6M.
Board of Trustees of The Leland Stanford Junior University first reported a position in Nautilus Biotechnolgy in Q2 2021 and held it in 3 quarters.
Board of Trustees of The Leland Stanford Junior University's Nautilus Biotechnolgy position peaked at $3.13M in Q2 2021.
82 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2022.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q1 2022, filed 13 May 2022.